{"id":14202,"date":"2026-06-26T01:13:01","date_gmt":"2026-06-26T01:13:01","guid":{"rendered":"https:\/\/pharmamachinecn.com\/?p=14202"},"modified":"2026-04-08T03:25:19","modified_gmt":"2026-04-08T03:25:19","slug":"granules-in-pharmaceutical-manufacturing","status":"publish","type":"post","link":"https:\/\/pharmamachinecn.com\/tr\/granules-in-pharmaceutical-manufacturing\/","title":{"rendered":"\u0130la\u00e7 \u00dcretiminde Gran\u00fcller"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u0130la\u00e7 \u00fcreticileri, s\u0131k\u0131 kalite standartlar\u0131n\u0131 kar\u015f\u0131layan ila\u00e7lar \u00fcretme konusunda s\u00fcrekli bir bask\u0131 alt\u0131ndad\u0131r. G\u00fcvenilir ila\u00e7 \u00fcretimini destekleyen temel fakt\u00f6rlerden biri gran\u00fclasyondur. \u0130nce tozlar\u0131 homojen par\u00e7ac\u0131klara d\u00f6n\u00fc\u015ft\u00fcrerek gran\u00fclasyon, malzemelerin kar\u0131\u015ft\u0131rma, s\u0131k\u0131\u015ft\u0131rma ve depolama a\u015famalar\u0131nda sergiledi\u011fi davran\u0131\u015flar\u0131 iyile\u015ftirir.<\/p>

\"\u0130la\u00e7
\u0130la\u00e7 \u00dcretiminde Gran\u00fcller.<\/strong><\/em><\/figcaption><\/figure>

Farkl\u0131 form\u00fclasyonlar, farkl\u0131 gran\u00fcl yap\u0131lar\u0131 gerektirir ve do\u011fru t\u00fcr\u00fcn se\u00e7ilmesi nihai \u00fcr\u00fcn\u00fc \u00f6nemli \u00f6l\u00e7\u00fcde etkileyebilir. Modifiye sal\u0131ml\u0131 gran\u00fcllerden s\u00fcspansiyonlu gran\u00fcllere kadar her t\u00fcr\u00fcn i\u015fleyi\u015fi farkl\u0131d\u0131r. Bu gran\u00fcllerin yap\u0131s\u0131, form\u00fclasyonlarda aktif ila\u00e7 maddesinin (API) homojenli\u011fini art\u0131rarak tutarl\u0131 bir dozaj\u0131n sa\u011flanmas\u0131na yard\u0131mc\u0131 olur.<\/p>

Bu k\u0131lavuz, farmas\u00f6tik form\u00fclasyonlarda kullan\u0131lan ba\u015fl\u0131ca gran\u00fcl t\u00fcrlerini, bunlar\u0131n ila\u00e7 \u00fcretimindeki uygulamalar\u0131n\u0131 ve avantajlar\u0131n\u0131 ele almaktad\u0131r. Ayr\u0131ca, bu gran\u00fcllerin \u00fcretilmesinde kullan\u0131lan gran\u00fclasyon tekniklerini ve bu s\u00fcre\u00e7lerin b\u00fcy\u00fck \u00f6l\u00e7ekli \u00fcretimi nas\u0131l destekledi\u011fini de incelemektedir.<\/p>

\u0130la\u00e7 Gran\u00fclleri Nedir?<\/b><\/strong><\/h2>
\"Tozdan
Tozdan gran\u00fcle d\u00f6n\u00fc\u015ft\u00fcrme. Kaynak:<\/i><\/b><\/em><\/strong>\u00a0<\/i><\/em>Temel T\u0131bbi Anahtar<\/i><\/u><\/em><\/a><\/figcaption><\/figure>

\u0130la\u00e7 gran\u00fclleri, daha b\u00fcy\u00fck ve daha homojen yap\u0131lar olu\u015fturan ince toz par\u00e7ac\u0131klar\u0131n\u0131n bir araya gelmesiyle olu\u015fan k\u00fcmelerdir. Par\u00e7ac\u0131k boyutlar\u0131 genellikle 0,2 ila 4 mm.<\/strong> Ara \u00fcr\u00fcn olarak kullan\u0131ld\u0131\u011f\u0131nda, gran\u00fcller genellikle daha k\u00fc\u00e7\u00fckt\u00fcr (0,2\u20130,5 mm).<\/strong> Ancak, \u015fu \u015fekilde ifade edildi\u011finde: a\u011f\u0131zdan al\u0131nan kat\u0131 ila\u00e7 formu (OSD),<\/strong> Bunlar daha b\u00fcy\u00fckt\u00fcr; genellikle 1 ile 4 mm aras\u0131ndad\u0131r.<\/p>

Gran\u00fcller, tozlar\u0131n kar\u0131\u015ft\u0131r\u0131larak kararl\u0131 agregalara d\u00f6n\u00fc\u015ft\u00fcr\u00fcld\u00fc\u011f\u00fc \u201cgran\u00fclasyon\u201d ad\u0131 verilen bir i\u015flemle \u00fcretilir. Nispeten dar boyut da\u011f\u0131l\u0131mlar\u0131 ve neredeyse k\u00fcresel \u015fekilleri, tozun ak\u0131\u015f\u0131n\u0131 ve i\u00e7erik homojenli\u011fini iyile\u015ftirir. Ayr\u0131ca, ince par\u00e7ac\u0131klar gran\u00fcller aras\u0131ndaki bo\u015fluklar\u0131 doldurarak daha iyi s\u0131k\u0131\u015ft\u0131r\u0131labilirlik sa\u011flar.<\/p>

Tozlara k\u0131yasla gran\u00fcllerin nem i\u00e7eri\u011fi daha y\u00fcksek ve mekanik mukavemetleri daha fazlad\u0131r. Bu \u00f6zellikler, toz olu\u015fumunu azalt\u0131r ve \u00fcretim s\u0131ras\u0131nda k\u0131r\u0131lmay\u0131 en aza indirir.<\/p>

A\u015fa\u011f\u0131daki \u015fekilde s\u0131n\u0131fland\u0131r\u0131lan ila\u00e7lar: Biyofarmas\u00f6tik S\u0131n\u0131fland\u0131rma Sistemi (BCS)<\/u><\/a>\u00a0S\u0131n\u0131f II ve S\u0131n\u0131f IV, gran\u00fclasyondan en fazla fayda sa\u011flayan s\u0131n\u0131flard\u0131r; zira bu i\u015flem \u00e7\u00f6z\u00fcn\u00fcrl\u00fc\u011f\u00fc ve ge\u00e7irgenli\u011fi art\u0131rarak \u00e7\u00f6z\u00fcnme h\u0131zlar\u0131n\u0131 iyile\u015ftirir.<\/p>

\u0130lac\u0131n\u0131z \u0130\u00e7in Hangi T\u00fcr Gran\u00fcl Uygun? <\/b><\/strong><\/h2>

\u0130la\u00e7 form\u00fclasyonunda kullan\u0131lan gran\u00fcl t\u00fcr\u00fcn\u00fcn se\u00e7imi, ilac\u0131n kararl\u0131l\u0131\u011f\u0131, \u00e7\u00f6z\u00fcn\u00fcrl\u00fc\u011f\u00fc ve istenen sal\u0131m profili gibi fakt\u00f6rlere ba\u011fl\u0131d\u0131r. \u0130\u015fte farmas\u00f6tik form\u00fclasyonlarda en \u00f6nemli d\u00f6rt gran\u00fcl t\u00fcr\u00fc:<\/p>

1. Gecikmeli Sal\u0131ml\u0131 Gran\u00fcller<\/b><\/strong><\/h3>

Gecikmeli sal\u0131n\u0131ml\u0131 gran\u00fcller, ilac\u0131n v\u00fccuda verildikten sonra sal\u0131n\u0131m h\u0131z\u0131n\u0131, s\u00fcresini ve yerini kontrol etmek \u00fczere form\u00fcle edilmi\u015ftir. Bu, kan dola\u015f\u0131m\u0131nda ilac\u0131n konsantrasyonunun sabit kalmas\u0131na yard\u0131mc\u0131 olur ve hedefe y\u00f6nelik sal\u0131n\u0131m sa\u011flar.<\/p>

Gran\u00fcller, kaplamal\u0131 veya kaplamas\u0131z olabilir ve ilac\u0131n sal\u0131n\u0131m\u0131n\u0131 d\u00fczenleyen \u00f6zel yard\u0131mc\u0131 maddeler i\u00e7erebilir. Sal\u0131n\u0131m profiline ba\u011fl\u0131 olarak, modifiye sal\u0131n\u0131ml\u0131 gran\u00fcller uzun s\u00fcreli sal\u0131n\u0131ml\u0131, gecikmeli sal\u0131n\u0131ml\u0131, uzat\u0131lm\u0131\u015f sal\u0131n\u0131ml\u0131 ve s\u00fcrekli sal\u0131n\u0131ml\u0131 olarak s\u0131n\u0131fland\u0131r\u0131labilir.<\/p>

2. Efervesan Gran\u00fcller<\/b><\/strong><\/h3>

Suya at\u0131ld\u0131klar\u0131nda, efervesan gran\u00fcller karbondioksit gaz\u0131 \u00fcretir ve bu da karakteristik k\u00f6p\u00fcklenmeyi olu\u015fturur. Bu reaksiyon, asidik bile\u015fenler ile bikarbonat bile\u015fikleri aras\u0131ndaki etkile\u015fim sonucu ger\u00e7ekle\u015fir. Bu form\u00fclasyonlarda yayg\u0131n olarak kullan\u0131lan bile\u015fenler aras\u0131nda sitrik asit, tartarik asit ve sodyum bikarbonat bulunur.<\/p>

Form\u00fclasyondaki ek yard\u0131mc\u0131 maddeler, tad\u0131 ve g\u00f6rsel \u00e7ekicili\u011fi art\u0131r\u0131r. S\u00fckroz veya aspartam gibi tatland\u0131r\u0131c\u0131lar, nane ya\u011f\u0131 gibi aroma maddeleri ve titanyum dioksit gibi renklendirici maddeler s\u0131kl\u0131kla eklenir. \u00c7o\u011fu durumda, efervesan reaksiyon ve tam par\u00e7alanma be\u015f dakika i\u00e7inde ger\u00e7ekle\u015fir. \u00a0<\/p>

3. Mide Asidine Dayan\u0131kl\u0131 Gran\u00fcller<\/b><\/strong><\/h3>

Mide asidine dayan\u0131kl\u0131 gran\u00fcller, midenin asidik ortam\u0131na dayanacak \u015fekilde tasarlanm\u0131\u015ft\u0131r. \u0130\u00e7eriklerini ancak pH de\u011ferinin daha y\u00fcksek oldu\u011fu ba\u011f\u0131rsa\u011fa ula\u015ft\u0131ktan sonra salarlar. Bu gecikmeli sal\u0131m \u00f6zelli\u011fi, aktif farmas\u00f6tik maddeyi (API) asidin neden oldu\u011fu bozulmaya kar\u015f\u0131 korur ve mide mukozas\u0131ndaki tahri\u015fi azalt\u0131r.<\/p>

Sonu\u00e7 olarak, bu gran\u00fcller genellikle mide ortam\u0131nda karars\u0131z olan veya mide zar\u0131n\u0131 tahri\u015f eden ila\u00e7lar\u0131 i\u00e7eren form\u00fclasyonlarda yayg\u0131n olarak kullan\u0131lmaktad\u0131r. Mide asidine diren\u00e7li \u00f6zellikler, \u00fcretim s\u0131ras\u0131nda gran\u00fcl y\u00fczeyine \u00f6zel enterik polimer kaplamalar uygulanarak elde edilir.<\/p>

Bu t\u00fcr form\u00fclasyonlar, sindirim sistemi rahats\u0131zl\u0131klar\u0131n\u0131n tedavisinde, \u00f6rne\u011fin omeprazol i\u00e7eren \u00fcr\u00fcnlerde yayg\u0131n olarak kullan\u0131lmaktad\u0131r. En iyi tedavi etkisini sa\u011flamak i\u00e7in, mide asidine dayan\u0131kl\u0131 gran\u00fcller genellikle yemeklerden \u00f6nce al\u0131n\u0131r.<\/p>

4. S\u00fcspansiyon Halindeki Gran\u00fcller<\/b><\/strong><\/h3>

S\u00fcspansiyon halindeki gran\u00fcller, tamamen \u00e7\u00f6z\u00fcnmek yerine s\u0131v\u0131 i\u00e7inde da\u011f\u0131l\u0131r. Suyla kar\u0131\u015ft\u0131r\u0131ld\u0131\u011f\u0131nda, gran\u00fcller, ince par\u00e7ac\u0131klar\u0131n s\u0131v\u0131n\u0131n her yerinde e\u015fit bir \u015fekilde da\u011f\u0131lm\u0131\u015f halde kald\u0131\u011f\u0131 bir s\u00fcspansiyon olu\u015fturur. Bu nedenle, s\u00fcspansiyon halindeki gran\u00fcller genellikle \u00e7ocuk ila\u00e7lar\u0131nda kullan\u0131l\u0131r<\/u><\/a>, \u00e7\u00fcnk\u00fc yutulmas\u0131 daha kolayd\u0131r ve ilac\u0131n kabul edilebilirli\u011fini art\u0131r\u0131r.<\/p>

Kullan\u0131m kolayl\u0131\u011f\u0131n\u0131n \u00f6tesinde, s\u00fcspansiyon gran\u00fclleri ayr\u0131ca zor \u00e7\u00f6z\u00fcnen bile\u015fiklerin ilac\u0131n v\u00fccuda ula\u015fmas\u0131n\u0131 da kolayla\u015ft\u0131r\u0131r. Ara\u015ft\u0131rmalar, oral s\u00fcspansiyonlar\u0131n genellikle di\u011fer bir\u00e7ok forma k\u0131yasla daha y\u00fcksek biyoyararlan\u0131m ve daha iyi stabilite sa\u011flad\u0131\u011f\u0131n\u0131 g\u00f6stermektedir. ila\u00e7 formlar\u0131<\/u><\/a>.<\/p>

Her \u00dcreticinin Bilmesi Gereken En \u00d6nemli Gran\u00fclasyon Y\u00f6ntemleri<\/b><\/strong><\/h2>

Do\u011fru gran\u00fclasyon y\u00f6nteminin se\u00e7imi, ilac\u0131n fiziksel ve kimyasal \u00f6zelliklerinin yan\u0131 s\u0131ra \u00fcretim hedeflerine de ba\u011fl\u0131d\u0131r. \u0130la\u00e7 \u00fcretiminde en yayg\u0131n olarak kullan\u0131lan iki teknik \u015funlard\u0131r: kuru gran\u00fclasyon ve \u0131slak gran\u00fclasyon<\/u><\/a>. Her bir t\u00fcr, tablet ve kaps\u00fcl \u00fcretimi i\u00e7in kendine \u00f6zg\u00fc avantajlar sunar.<\/p>

1. Kuru Gran\u00fclasyon <\/b><\/strong><\/h3>

Kuru gran\u00fclasyon, farmas\u00f6tik bile\u015fenlerin neme duyarl\u0131 oldu\u011fu veya \u0131slak gran\u00fclasyon sonras\u0131nda etkili bir \u015fekilde s\u0131k\u0131\u015ft\u0131r\u0131lamad\u0131\u011f\u0131 durumlarda kullan\u0131l\u0131r. Bu i\u015flemde, s\u0131v\u0131lar veya ba\u011flay\u0131c\u0131lar yerine, tozlar\u0131 gran\u00fcllere d\u00f6n\u00fc\u015ft\u00fcrmek i\u00e7in mekanik bas\u0131n\u00e7 kullan\u0131l\u0131r.<\/p>

\"Kuru
Kuru Gran\u00fclasyon<\/strong><\/em><\/span><\/a><\/figcaption><\/figure>

En yayg\u0131n iki kuru gran\u00fclasyon tekni\u011fi, slugging ve silindir s\u0131k\u0131\u015ft\u0131rmad\u0131r. Slugging y\u00f6nteminde, tozlar a\u011f\u0131r hizmet tipi presler kullan\u0131larak b\u00fcy\u00fck tabletler halinde s\u0131k\u0131\u015ft\u0131r\u0131l\u0131r ve ard\u0131ndan gran\u00fcller haline getirilmek \u00fczere \u00f6\u011f\u00fct\u00fcl\u00fcr. Buna kar\u015f\u0131l\u0131k, silindir s\u0131k\u0131\u015ft\u0131rma y\u00f6nteminde d\u00f6nen silindirler arac\u0131l\u0131\u011f\u0131yla s\u00fcrekli bas\u0131n\u00e7 uygulanarak kat\u0131 bir tabaka olu\u015fturulur ve bu tabaka daha sonra gran\u00fcllere ayr\u0131\u015ft\u0131r\u0131l\u0131r.<\/p>

Son zamanlarda kaydedilen geli\u015fmeler sayesinde pn\u00f6matik kuru gran\u00fclasyon<\/u><\/a>, malzeme kayb\u0131n\u0131 en aza indirirken g\u00f6zenekli ve y\u00fcksek oranda s\u0131k\u0131\u015ft\u0131r\u0131labilir gran\u00fcller \u00fcreten, geli\u015ftirilmi\u015f bir y\u00f6ntem.<\/p>

2. Islak Gran\u00fclasyon <\/b><\/strong><\/h3>
\"Islak
Islak Gran\u00fclasyon<\/strong><\/em><\/span><\/a><\/figcaption><\/figure>

Islak gran\u00fclasyon, ila\u00e7 \u00fcretiminde en geleneksel ve en yayg\u0131n olarak kullan\u0131lan gran\u00fclasyon y\u00f6ntemidir. Bu i\u015flemde, par\u00e7ac\u0131klar\u0131n birbirine yap\u0131\u015fmas\u0131n\u0131 sa\u011flamak amac\u0131yla toz kar\u0131\u015f\u0131m\u0131na su, etanol veya izopropanol gibi bir gran\u00fclasyon s\u0131v\u0131s\u0131 ile birlikte s\u0131v\u0131 bir ba\u011flay\u0131c\u0131 eklenir. Bu a\u015famada, gran\u00fcl haline getirilebilen nemli bir k\u00fctle olu\u015fur.<\/p>

Daha sonra \u0131slak k\u00fctle, homojen boyutlu gran\u00fcller elde etmek \u00fczere bir elekten ge\u00e7irilir. \u015eekillendirme i\u015fleminden sonra gran\u00fcller, fazla nemi gidermek amac\u0131yla kurutulur. Kurutulan malzeme daha sonra istenen par\u00e7ac\u0131k boyutu da\u011f\u0131l\u0131m\u0131n\u0131 elde etmek \u00fczere \u00f6\u011f\u00fct\u00fcl\u00fcr ve elenir.<\/p>

Zamanla, \u0131slak gran\u00fclasyon geleneksel bi\u00e7iminin \u00f6tesine ge\u00e7mi\u015ftir. Ters \u0131slak gran\u00fclasyon, buharl\u0131 gran\u00fclasyon, nemle aktive edilen kuru gran\u00fclasyon, termal yap\u0131\u015fma gran\u00fclasyonu, eriyik gran\u00fclasyonu, dondurarak gran\u00fclasyon ve k\u00f6p\u00fck gran\u00fclasyonu dahil olmak \u00fczere bir\u00e7ok geli\u015fmi\u015f varyasyon geli\u015ftirilmi\u015ftir.<\/p>

Gran\u00fcller \u00dcretimi Nas\u0131l Daha G\u00fcvenli, Daha H\u0131zl\u0131 ve Daha G\u00fcvenilir Hale Getiriyor?<\/b><\/strong><\/h2>
\"Y\u00fcksek
Y\u00fcksek H\u0131zl\u0131 H\u0131zl\u0131 Kar\u0131\u015ft\u0131r\u0131c\u0131 Gran\u00fclat\u00f6r<\/span><\/a>.<\/em><\/figcaption><\/figure>

Gran\u00fclasyon, ila\u00e7 \u00fcretiminin iyile\u015ftirilmesinde \u00f6nemli bir rol oynar. Tozlar\u0131 gran\u00fcllere d\u00f6n\u00fc\u015ft\u00fcrerek, \u00fcreticiler i\u015fleme ve depolama a\u015famalar\u0131nda kullan\u0131m\u0131 daha kolay olan par\u00e7ac\u0131klar elde ederler. \u0130la\u00e7 \u00fcretiminde gran\u00fcl kullan\u0131m\u0131n\u0131n ba\u015fl\u0131ca avantajlar\u0131 \u015funlard\u0131r:<\/p>

1. Toz Kontrol\u00fc <\/b><\/strong><\/h3>

Kar\u0131\u015ft\u0131rma, aktarma veya s\u0131k\u0131\u015ft\u0131rma i\u015flemleri s\u0131ras\u0131nda ince toz par\u00e7ac\u0131klar\u0131 havaya kar\u0131\u015fabilir ve bu da \u00fcretim tesislerinde \u00fcr\u00fcn kayb\u0131na ve g\u00fcvenlik risklerine yol a\u00e7abilir. Gran\u00fcller bu sorunu \u00f6nemli \u00f6l\u00e7\u00fcde azalt\u0131r. Serbest tozlara g\u00f6re daha b\u00fcy\u00fck ve a\u011f\u0131r olduklar\u0131 i\u00e7in daha az toz olu\u015ftururlar, havadan kaynaklanan kirlenmeyi en aza indirirler ve operat\u00f6rlerin korunmas\u0131na yard\u0131mc\u0131 olurlar.<\/p>

2. Geli\u015ftirilmi\u015f S\u0131k\u0131\u015ft\u0131r\u0131labilirlik <\/b><\/strong><\/h3>

Gran\u00fcller, tablet \u00fcretiminde gev\u015fek tozlara k\u0131yasla daha verimli bir \u015fekilde s\u0131k\u0131\u015ft\u0131r\u0131l\u0131r. Yap\u0131sal formlar\u0131, par\u00e7ac\u0131klar\u0131n bas\u0131n\u00e7 alt\u0131nda yeniden d\u00fczenlenmesine ve birbirine ba\u011flanmas\u0131na olanak tan\u0131r; bu da daha y\u00fcksek sertli\u011fe ve daha iyi yap\u0131sal b\u00fct\u00fcnl\u00fc\u011fe sahip tabletlerin elde edilmesini sa\u011flar. Bu durum ayn\u0131 zamanda tablet a\u011f\u0131rl\u0131\u011f\u0131n\u0131n tutarl\u0131l\u0131\u011f\u0131n\u0131 ve do\u011fru dozajlamay\u0131 destekleyerek genel \u00fcr\u00fcn kalitesine katk\u0131da bulunur.<\/p>

3. Ak\u0131\u015fkanl\u0131\u011f\u0131n Art\u0131r\u0131lmas\u0131 <\/b><\/strong><\/h3>

Gev\u015fek tozlar, ince ve d\u00fczensiz par\u00e7ac\u0131k boyutlar\u0131 nedeniyle genellikle haznelerden ve besleme sistemlerinden tutars\u0131z bir \u015fekilde akar. \u00d6te yandan, gran\u00fcller daha p\u00fcr\u00fczs\u00fcz y\u00fczeylere ve daha b\u00fcy\u00fck k\u00fctleye sahiptir; bu da i\u015fleme ekipmanlar\u0131ndan daha d\u00fczg\u00fcn bir \u015fekilde akmalar\u0131n\u0131 sa\u011flar. Bu istikrarl\u0131 ak\u0131\u015f, kal\u0131plar\u0131n, kaps\u00fcllerin ve paketleme \u00fcnitelerinin g\u00fcvenilir bir \u015fekilde doldurulmas\u0131n\u0131 garanti eder ve \u00fcretim h\u0131z\u0131n\u0131n ve tutarl\u0131l\u0131\u011f\u0131n\u0131n art\u0131r\u0131lmas\u0131na yard\u0131mc\u0131 olur.<\/p>

4. Daha \u0130yi Kararl\u0131l\u0131k <\/b><\/strong><\/h3>

Gran\u00fclasyon, i\u015fleme s\u0131ras\u0131nda koruyucu kaplamalar veya stabilizat\u00f6r yard\u0131mc\u0131 maddeler eklenerek hassas ila\u00e7 maddelerinin stabilitesini art\u0131rabilir. Bu ilaveler, ilac\u0131n etkinli\u011fini korumaya ve nihai \u00fcr\u00fcn\u00fcn raf \u00f6mr\u00fcn\u00fc uzatmaya yard\u0131mc\u0131 olur. Ayr\u0131ca, enterik kaplamal\u0131 gran\u00fcller, aside duyarl\u0131 ila\u00e7lar i\u00e7in hedefli koruma sa\u011flayarak mide gibi d\u00fc\u015f\u00fck pH\u2019l\u0131 ortamlarda bozulmay\u0131 \u00f6nler.<\/p>

5. Ayr\u0131\u015fmay\u0131 ve Yap\u0131\u015fmay\u0131 \u00d6nler<\/b><\/strong><\/h3>

Toz kar\u0131\u015f\u0131mlar\u0131nda, farkl\u0131 boyut veya yo\u011funluktaki par\u00e7ac\u0131klar i\u015fleme s\u0131ras\u0131nda birbirinden ayr\u0131labilir ve bu da tutars\u0131z dozajlamaya yol a\u00e7ar. Gran\u00fclasyon, bile\u015fenleri her bir par\u00e7ac\u0131\u011f\u0131n i\u00e7inde birbirine ba\u011flayarak bu sorunu \u00e7\u00f6zer. Gran\u00fcller, gev\u015fek tozlara g\u00f6re daha b\u00fcy\u00fck ve daha dayan\u0131kl\u0131 olduklar\u0131 i\u00e7in, ayn\u0131 zamanda yap\u0131\u015ft\u0131rma ve toplama<\/u><\/a>\u00a0tablet s\u0131k\u0131\u015ft\u0131rma i\u015flemi s\u0131ras\u0131nda.<\/p>

SSS<\/b><\/strong><\/h2>

1. <\/b><\/strong>Kuru gran\u00fclasyon, \u0131slak gran\u00fclasyon tekniklerinden temel olarak ne a\u00e7\u0131dan farkl\u0131d\u0131r?<\/b><\/strong>\u00a0<\/b><\/strong><\/h3>

Kuru y\u00f6ntemler, par\u00e7ac\u0131klar\u0131 birbirine ba\u011flamak i\u00e7in tamamen a\u015f\u0131r\u0131 mekanik s\u0131k\u0131\u015ft\u0131rmaya dayan\u0131r; s\u0131v\u0131 ba\u011flay\u0131c\u0131lar ve \u0131s\u0131l kurutma i\u015flemlerinden tamamen ka\u00e7\u0131n\u0131l\u0131r. Buna kar\u015f\u0131l\u0131k, \u0131slak tekniklerde su bazl\u0131 veya organik \u00e7\u00f6z\u00fcc\u00fcler kullan\u0131larak k\u0131lcal k\u00f6pr\u00fcler olu\u015fturulur ve bu da kurutma sonras\u0131nda \u00fcst\u00fcn bir nihai \u00e7ekme mukavemeti sa\u011flar.<\/p>

2. <\/b><\/strong>Islak gran\u00fclasyon termodinami\u011finde k\u0131lcal durumu belirleyen unsur nedir?<\/b><\/strong>\u00a0<\/b><\/strong><\/h3>

K\u0131lcal durum, s\u0131v\u0131 ba\u011flay\u0131c\u0131n\u0131n birincil par\u00e7ac\u0131klar aras\u0131ndaki t\u00fcm bo\u015fluklar\u0131 tamamen doldurarak hapsolmu\u015f havay\u0131 d\u0131\u015far\u0131 itmesiyle ortaya \u00e7\u0131kar. Bu durum, k\u0131lcal bas\u0131nc\u0131 ve aray\u00fczey kuvvetlerini en \u00fcst d\u00fczeye \u00e7\u0131kararak, termal kurutma \u00f6ncesinde en \u00fcst d\u00fczeyde yap\u0131sal b\u00fct\u00fcnl\u00fck sa\u011flar.<\/p>

3. <\/b><\/strong>Ak\u0131\u015fkan yatakl\u0131 gran\u00fclasyonun temel i\u015flevi nedir?<\/b><\/strong>\u00a0<\/b><\/strong><\/h3>

Ak\u0131\u015fkan yatak sistemleri, \u0131s\u0131t\u0131lm\u0131\u015f, y\u00fcksek h\u0131zl\u0131 bir hava ak\u0131m\u0131 i\u00e7inde kohezif toz yataklar\u0131n\u0131 havada as\u0131l\u0131 tutarken, ayn\u0131 anda y\u00fczen par\u00e7ac\u0131klar\u0131n \u00fczerine s\u0131v\u0131 bir ba\u011flay\u0131c\u0131y\u0131 p\u00fcsk\u00fcrt\u00fcr. Bu teknoloji, k\u00fctle olu\u015fturma ve termal kurutma i\u015flemlerini tek bir s\u00fcrekli i\u015flemde birle\u015ftirerek, son derece g\u00f6zenekli ve homojen aglomeralar \u00fcretir.<\/p>

4. <\/b><\/strong>Eritme gran\u00fclasyonu hangi somut \u00fcretim avantajlar\u0131n\u0131 sunar?<\/b><\/strong>\u00a0<\/b><\/strong><\/h3>

50\u00b0C ile 90\u00b0C aras\u0131nda s\u0131v\u0131 hale gelen termoplastik polimerlerin kullan\u0131lmas\u0131yla, eriyik gran\u00fclasyon y\u00f6ntemi s\u0131v\u0131 \u00e7\u00f6z\u00fcc\u00fc kullan\u0131m\u0131n\u0131 tamamen ortadan kald\u0131r\u0131r. So\u011fuma s\u0131ras\u0131nda erimi\u015f ba\u011flay\u0131c\u0131 an\u0131nda son derece sa\u011flam kat\u0131 k\u00f6pr\u00fcler haline gelir; bu da \u00fcretim s\u00fcrelerini \u00f6nemli \u00f6l\u00e7\u00fcde k\u0131salt\u0131r ve i\u015fletme maliyetlerini d\u00fc\u015f\u00fcr\u00fcr.<\/p>

\u0130la\u00e7 \u00dcretim S\u00fcrecinizi Bir \u00dcst D\u00fczeye Ta\u015f\u0131y\u0131n <\/b><\/strong><\/h2>

\u0130la\u00e7 form\u00fclasyonlar\u0131ndaki farkl\u0131 gran\u00fcl t\u00fcrlerini anlamak, \u00fcreticilerin ila\u00e7 \u00fcretiminin kalitesini art\u0131rmalar\u0131na yard\u0131mc\u0131 olur. \u00d6nemli olan, uygun bir gran\u00fclasyon stratejisi se\u00e7meden \u00f6nce form\u00fclasyon hedeflerini, ilac\u0131n \u00f6zelliklerini ve \u00fcretim \u00f6l\u00e7e\u011fini de\u011ferlendirmektir.<\/p>

Form\u00fclasyon ve i\u015fleme gereksinimleri netle\u015fti\u011finde, bir sonraki ad\u0131m bu hedefleri destekleyebilecek ekipman\u0131 se\u00e7mektir. G\u00fcvenilir bir ila\u00e7 ekipman\u0131 tedarik\u00e7isi ar\u0131yorsan\u0131z, Finetech<\/i><\/u><\/em><\/a>\u00a0m\u00fckemmel bir se\u00e7enektir.<\/p>

Kat\u0131 dozaj \u00fcretimi i\u00e7in h\u0131zl\u0131 kar\u0131\u015ft\u0131r\u0131c\u0131l\u0131 gran\u00fclat\u00f6rler ve eksiksiz gran\u00fclasyon hatlar\u0131 dahil olmak \u00fczere \u00e7e\u015fitli gran\u00fclasyon \u00e7\u00f6z\u00fcmleri sunuyoruz. 25 ila 1500 L aras\u0131nda de\u011fi\u015fen kapasitelere sahip bu sistemler, farkl\u0131 \u00fcretim \u00f6l\u00e7eklerini destekleyecek \u015fekilde tasarlanm\u0131\u015ft\u0131r. Tesisiniz i\u00e7in en uygun ekipman\u0131 se\u00e7mek \u00fczere uzmanlar\u0131m\u0131zla hemen ileti\u015fime ge\u00e7in.<\/p>

Referanslar:<\/strong><\/h2>

Gran\u00fclasyon teknikleri ve teknolojileri: son geli\u015fmeler<\/strong><\/em><\/span><\/a>.<\/p>

Eczac\u0131l\u0131kta Gran\u00fcl Anlam\u0131<\/strong><\/em><\/span><\/a>.<\/p>

\u0130la\u00e7 end\u00fcstrisinde gran\u00fclasyonun incelenmesi: sel\u00fcloz eterlerinin rol\u00fc<\/strong><\/em><\/span><\/a>.<\/p>

8. B\u00f6l\u00fcm: Gran\u00fclasyon<\/strong> <\/em><\/span><\/a><\/p>

Telif Hakk\u0131 Uyar\u0131s\u0131:\u00a0<\/b><\/h2>

Finetech Group'un \u00f6nceden a\u00e7\u0131k yaz\u0131l\u0131 onay\u0131 olmadan bu web sitesindeki herhangi bir i\u00e7eri\u011fi \u00e7o\u011faltamaz, de\u011fi\u015ftiremez, yay\u0131nlayamaz, g\u00f6r\u00fcnt\u00fcleyemez, iletemez veya herhangi bir \u015fekilde istismar edemezsiniz veya bu t\u00fcr i\u00e7eri\u011fi herhangi bir veritaban\u0131 olu\u015fturmak i\u00e7in kullanamazs\u0131n\u0131z. \u0130\u00e7eri\u011fi kullanma izni i\u00e7in l\u00fctfen ileti\u015fime ge\u00e7in: info@pharmamachinecn.com<\/span><\/a><\/p>

Yasal Uyar\u0131:<\/b><\/h2>

Bu makalede yer alan bilgiler yaln\u0131zca genel bilgilendirme ama\u00e7l\u0131d\u0131r. \u015eirket, herhangi bir bilginin do\u011frulu\u011funu, g\u00fcncelli\u011fini veya eksiksizli\u011fini garanti etmez ve \u015eirket, bu makalenin i\u00e7eri\u011findeki hatalar veya eksiklikler i\u00e7in hi\u00e7bir sorumluluk kabul etmez.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

Pharmaceutical manufacturers face constant pressure to produce medicines that meet strict quality standards. One key factor that supports reliable drug […]<\/p>\n","protected":false},"author":1,"featured_media":14241,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[61],"tags":[],"class_list":["post-14202","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmaceutical-technology"],"acf":[],"_links":{"self":[{"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/posts\/14202","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/comments?post=14202"}],"version-history":[{"count":7,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/posts\/14202\/revisions"}],"predecessor-version":[{"id":14249,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/posts\/14202\/revisions\/14249"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/media\/14241"}],"wp:attachment":[{"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/media?parent=14202"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/categories?post=14202"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/tags?post=14202"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}